scholarly journals Electrodiagnostic effect of Armeo® Robotic Therapy versus Conventional Therapy in Erb’s Palsy Children

2021 ◽  
Vol 12 (Suppl 1) ◽  
Keyword(s):  
Conventional Therapy ◽  
Erb’S Palsy ◽  
Robotic Therapy

scholarly journals Robotic Assisted Upper Limb Training Post Stroke: A Randomized Control Trial Using Combinatory Approach Toward Reducing Workforce Demands

2021 ◽  
Vol 12 ◽  
Author(s):  
Aamani Budhota ◽  
Karen S. G. Chua ◽  
Asif Hussain ◽  
Simone Kager ◽  
Adèle Cherpin ◽  
...  
Keyword(s):  
Motor Function ◽  
Upper Limb ◽  
Conventional Therapy ◽  
Randomized Control Trial ◽  
Potential Method ◽  
Clinical Trial Registration ◽  
Upper Limb Rehabilitation ◽  
Post Stroke ◽  
Robotic Therapy ◽  
Randomized Control

Post stroke upper limb rehabilitation is a challenging problem with poor outcomes as 40% of survivors have functionally useless upper limbs. Robot-aided therapy (RAT) is a potential method to alleviate the effort of intensive, task-specific, repetitive upper limb exercises for both patients and therapists. The present study aims to investigate how a time matched combinatory training scheme that incorporates conventional and RAT, using H-Man, compares with conventional training toward reducing workforce demands. In a randomized control trial (NCT02188628, www.clinicaltrials.gov), 44 subacute to chronic stroke survivors with first-ever clinical stroke and predominant arm motor function deficits were recruited and randomized into two groups of 22 subjects: Robotic Therapy (RT) and Conventional Therapy (CT). Both groups received 18 sessions of 90 min; three sessions per week over 6 weeks. In each session, participants of the CT group received 90 min of 1:1 therapist-supervised conventional therapy while participants of the RT group underwent combinatory training which consisted of 60 min of minimally-supervised H-Man therapy followed by 30 min of conventional therapy. The clinical outcomes [Fugl-Meyer (FMA), Action Research Arm Test and, Grip Strength] and the quantitative measures (smoothness, time efficiency, and task error, derived from two robotic assessment tasks) were independently evaluated prior to therapy intervention (week 0), at mid-training (week 3), at the end of training (week 6), and post therapy (week 12 and 24). Significant differences within group were observed at the end of training for all clinical scales compared with baseline [mean and standard deviation of FMA score changes between baseline and week 6; RT: Δ4.41 (3.46) and CT: Δ3.0 (4.0); p < 0.01]. FMA gains were retained 18 weeks post-training [week 24; RT: Δ5.38 (4.67) and week 24 CT: Δ4.50 (5.35); p < 0.01]. The RT group clinical scores improved similarly when compared to CT group with no significant inter-group at all time points although the conventional therapy time was reduced to one third in RT group. There were no training-related adverse side effects. In conclusion, time matched combinatory training incorporating H-Man RAT produced similar outcomes compared to conventional therapy alone. Hence, this study supports a combinatory approach to improve motor function in post-stroke arm paresis.Clinical Trial Registration:www.ClinicalTrials.gov, identifier: NCT02188628.

scholarly journals Effects of robotic intervention associated with conventional therapy on gait speed and resistance and trunk control in stroke patients

2019 ◽  
Vol 26 (3) ◽  
Author(s):  
Cristhina Bonilha Huster Siegle ◽  
Joyce Karoline Friosi de Carvalho ◽  
Daniela Mitiyo Odagiri Utiyama ◽  
Denise Matheus ◽  
Fabio Marcon Alfieri ◽  
...  
Keyword(s):  
Gait Speed ◽  
Conventional Therapy ◽  
Chronic Phase ◽  
Mean Value ◽  
Wilcoxon Test ◽  
Walk Test ◽  
Trunk Control ◽  
Final Value ◽  
Robotic Therapy ◽  
Before And After

Objective: To verify the effects of gait and robotic stair training with G-EO System, associated with conventional rehabilitation, on gait speed and endurance and trunk control of stroke participants. Methods: Retrospective study with 28 participants in the chronic phase of the disease. G-EO System was used for gait and stair robotic intervention. 20-session protocol of 20 minutes associated with conventional multidisciplinary therapy. The 10-meter Walk Test (10mWT), 6-minute Walk Test (6MWT) and Trunk Impairment Scale (TIS) tools were used. P values <0.05 were considered statistically significant with Wilcoxon test before and after intervention. Results: Significant differences found in the tests. TIS presented initial mean value of 14.29 (± 5.30) and final value of 17.04 (± 4.49), with p = 0.00044. 10mWT presented average initial velocity of 0.498 m/s (± 0.27) and final velocity of 0.597 m/s (± 0.32), p = 0.00008. 6mWT presented mean initial value of 155.89m (± 85.96) and final value of 195.39m (± 109.78), p = 0.00152. Conclusion: Gait and stair robotic therapy, associated with conventional therapy, was effective in promoting increased speed, endurance aptitude for greater gait distances and trunk control in individuals with chronic stroke after stroke.

Circulating Anticoagulant (Antifactor VIII) Treated with Immunosuppressive Drugs

1969 ◽  
Vol 21 (02) ◽  
pp. 249-258 ◽  
Author(s):  
L. A Sherman ◽  
M. A Goldstein ◽  
H. S Sise
Keyword(s):  
Factor Viii ◽  
Conventional Therapy ◽  
Immunosuppressive Drugs ◽  
The Other ◽  
Not Given ◽  
Factor Viii Concentrates ◽  
Short Courses

SummaryThree cases have been presented who had a circulating antifactor VIII anticoagulant developing spontaneously in non-hemophilic subjects. Following two short courses of azathioprine in one case there were transient incomplete remissions of a degree not seen in the previous 4 months of observation. In the other two cases complete remissions were observed within three weeks of beginning administration of 6-mercaptopurine. In one of these, a brief relapse was retreated successfully. In 4 other cases not given these drugs and in cases reported in the literature, such a rapid remission was not seen to occur spontaneously and happened only infrequently in cases given corticosteroids. On the basis of this experience, we suggest that in the treatment of antifactor VIII, if the disorder shows no improvement with conventional therapy (blood, factor VIII concentrates, and corticosteroids), a trial with immunosuppressive drugs is warranted.

Sign in / Sign up

Export Citation Format

Share Document